Seung-Hoon Beom

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Cross Sectional

Transforming Growth Factor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical activity of transforming growth factor-β inhibitor vactosertib in combination with imatinib in desmoid tumors: a multicenter phase Ib/II study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye-Won Lee, Jun Yong Park, Seung-Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma. Journal of cancer research and clinical oncology 147 (10) (2021)